NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

It just appears that LP is using this PR as vehicle to hint Merck's involvement.

I read it differently. I believe LP views the success that Merck has achieved with Keytruda, an immune therapy approved in over 26 indications, as a blueprint for what she intends to achieve with DCVax, and she believes that Dr. Duffy’s experience with Keytruda at Merck can help her achieve this.

Linda Powers, CEO of NW Bio, noted that “Dr. Duffy’s experience with immune therapies for cancer and one of the most successful product development programs in the field will be an invaluable addition to our team. We at NW Bio could not be more excited about Dr. Duffy’s choice to join us and help realize the broad potential of DCVax.”